Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trial.

CONCLUSIONS.: Our study revealed that pregabalin, as an augmenting medication, is more effective than placebo in the treatment of patients with resistant OCD.
PMID: 31648655 [PubMed - as supplied by publisher]

Source: CNS Spectrums - October 24, 2019 Category: Neurology Authors: Mowla A, Ghaedsharaf M Tags: CNS Spectr Source Type: research